Katherine Smith, NP
Adult Health · Anchorage, AKNPI 1144719535
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,728 of the $5,489 with a category attached, or 86.1%. 25 manufacturers reported payments, led by Medtronic at 40.1% of the total. 2025 is the largest year on record at $1,778, 2.7 times the $647 reported in 2021. Among adult health clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$827
- Abbott$620
- Collegium Pharmaceutical, Inc.$301
- Nevro Corp.$252
- Teva Pharmaceuticals USA, Inc.$205
- plus $1K from 19 others
What the payments were for
- Travel & lodging$71613%
- Food & beverage$4,72886%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 78 | $2,202 |
| AbbVie | 36 | $827 |
| Abbott | 12 | $620 |
| Collegium Pharmaceutical, Inc. | 15 | $301 |
| Nevro Corp. | 11 | $252 |
| Teva Pharmaceuticals USA, Inc. | 11 | $205 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $139 |
| Pfizer | 7 | $118 |
| Merz Pharmaceuticals, LLC | 3 | $112 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $107 |
| Biohaven Pharmaceuticals, Inc. | 5 | $95 |
| Vertex | 2 | $64 |
| IBSA Pharma Inc. | 3 | $61 |
| Averitas Pharma Inc. | 2 | $58 |
| Amgen | 3 | $52 |
| Si-bone, Inc. | 3 | $51 |
| GRT US Holding, Inc. | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Globus Medical | 1 | $22 |
| Lundbeck LLC | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$927
- Omnia$139
- Accurian$138
- PROCLAIM$122
- ETERNA$117
How this compares
$5,489 in reported general payments places this provider in the 95th percentile of 22 adult health providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 15 | $10,579 |
| LinzessLinaclotide | 12 | $7,312 |
| Xtampza ErOxycodone Myristate | 15 | $6,979 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 107 | $4,146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 117 | $3,184 |
| Oxycodone Hcl | 105 | $2,186 |
| Morphine Sulfate ErMorphine Sulfate | 70 | $1,635 |
| Lidocaine | 16 | $1,017 |
| Gabapentin | 54 | $609 |
| Fentanyl | 11 | $507 |
| Pregabalin | 34 | $454 |
| Tizanidine Hcl | 47 | $411 |
| Tramadol Hcl | 19 | $385 |
| Morphine Sulfate | 15 | $382 |
| Hydromorphone Hcl | 15 | $253 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $827 | $7,31212 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $301 | $6,97915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 22 adult health providers in Alaska.
Other adult health in Anchorage
- Jennifer HuntAnchorage$4K
- Sandra MahoneyAnchorage$2K
- Melanie BolesAnchorage$2K
- Shannon BakerAnchorage$797
- Amanda EllisAnchorage$624
- Megan HathcoatAnchorage$574
- Rebecca LibalAnchorage$376
- Amanda BaileyAnchorage$218
- Lisa TownsendAnchorage$210
- Shantai McDermottAnchorage$196
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.